http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2371358-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 |
| filingDate | 2006-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f260a934ab20e332f06079e8759040dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528ff0067ec2e1376333800a2dcfaa3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c0f42763123125061c907fe2acf5782 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72512a163757dd9434994201f571ec91 |
| publicationDate | 2011-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2371358-T3 |
| titleOfInvention | BENZOIMIDAZOL CAPAZ COMPOSITE OF INHIBITING PROSTAGLANDINA D SINTETASA. |
| abstract | Benzimidazole compound represented by Formula (I) in which X 1 is oxygen or carbonyl, and R 1 is a furan ring having 1 to 3 substituents or a pyrrole ring that can have 1 to 3 substituents, and the substituents in the pyrrole ring or in the furan ring, they are selected from the group consisting of halogen, cyano, nitro, C1-6 alkyl which may have one or more substituents, C3-7 cycloalkyl which may have one or more substituents , C2-6 alkenyl which may have one or more substituents, and - (C = O) -R 2; R 2 is hydrogen, hydroxy, C 1-6 alkyl which may have one or more substituents, C 1-6 alkoxy which may have one or more substituents, or -NR 3 R 4; and R 3 and R 4 are the same or different, and are each hydrogen, hydroxy, C1-6 alkyl which may have one or more substituents, C1-6 alkoxy which may have one or more substituents, amino, mono- or di (C1-C6 alkyl) amino that may have one or more substituents, C6-14 aryl that may have one or more substituents, or a saturated or unsaturated heterocyclic group that may have one or more substituents, or R 3 and R 4 taken together with the adjacent nitrogen atom, may form a saturated cyclic amino group or unsaturated may have, in the ring structure, 1 or 2 heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, in addition atom adjacent nitrogen, and the cyclic amino group may have one or more substituents; or a salt thereof. |
| priorityDate | 2005-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 450.